Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Oxidatively Locked [Co₂L₃]6+ Cylinders Derived from Bis(bidentate) 2-Pyridyl-1,2,3-triazole "Click" Ligands: Synthesis, Stability, and Antimicrobial Studies.

Vasdev RA, Preston D, Scottwell SØ, Brooks HJ, Crowley JD, Schramm MP.

Molecules. 2016 Nov 16;21(11). pii: E1548.

2.

Prevalence of Shiga toxin-producing and enteropathogenic Escherichia coli marker genes in diarrhoeic stools in a New Zealand catchment area.

Thomas RR, Brooks HJ, O'Brien R.

J Clin Pathol. 2017 Jan;70(1):81-84. doi: 10.1136/jclinpath-2016-203882. Epub 2016 Oct 3.

PMID:
27698249
3.

Antimicrobial Properties of Tris(homoleptic) Ruthenium(II) 2-Pyridyl-1,2,3-triazole "Click" Complexes against Pathogenic Bacteria, Including Methicillin-Resistant Staphylococcus aureus (MRSA).

Kumar SV, Scottwell SØ, Waugh E, McAdam CJ, Hanton LR, Brooks HJ, Crowley JD.

Inorg Chem. 2016 Oct 3;55(19):9767-9777. Epub 2016 Sep 22.

PMID:
27657170
4.

Reducing the Oxidation Level of Dextran Aldehyde in a Chitosan/Dextran-Based Surgical Hydrogel Increases Biocompatibility and Decreases Antimicrobial Efficacy.

Chan M, Brooks HJ, Moratti SC, Hanton LR, Cabral JD.

Int J Mol Sci. 2015 Jun 16;16(6):13798-814. doi: 10.3390/ijms160613798.

5.

In vitro biocompatibility and cellular interactions of a chitosan/dextran-based hydrogel for postsurgical adhesion prevention.

Aziz MA, Cabral JD, Brooks HJ, McConnell MA, Fitzpatrick C, Hanton LR, Moratti SC.

J Biomed Mater Res B Appl Biomater. 2015 Feb;103(2):332-41. doi: 10.1002/jbm.b.33206. Epub 2014 May 29.

PMID:
24889797
6.

Modern microbiology - a quiet revolution with many benefits.

Brooks HJ.

Australas Med J. 2013 Jul 31;6(7):378-81. doi: 10.4066/AMJ.2013.1830. Print 2013.

7.

Bacterial contamination of unused, disposable non-sterile gloves on a hospital orthopaedic ward.

Hughes KA, Cornwall J, Theis JC, Brooks HJ.

Australas Med J. 2013 Jun 30;6(6):331-8. doi: 10.4066/AMJ.2013.1675. Print 2013.

8.

Antibiotic susceptibility of Moraxella catarrhalis biofilms in a continuous flow model.

Matejka KM, Bremer PJ, Tompkins GR, Brooks HJ.

Diagn Microbiol Infect Dis. 2012 Dec;74(4):394-8. doi: 10.1016/j.diagmicrobio.2012.08.021. Epub 2012 Oct 18.

PMID:
23083637
9.

Antimicrobial properties of a chitosan dextran-based hydrogel for surgical use.

Aziz MA, Cabral JD, Brooks HJ, Moratti SC, Hanton LR.

Antimicrob Agents Chemother. 2012 Jan;56(1):280-7. doi: 10.1128/AAC.05463-11. Epub 2011 Oct 24.

10.

Novel clonal complexes with an unknown animal reservoir dominate Campylobacter jejuni isolates from river water in New Zealand.

Carter PE, McTavish SM, Brooks HJ, Campbell D, Collins-Emerson JM, Midwinter AC, French NP.

Appl Environ Microbiol. 2009 Oct;75(19):6038-46. doi: 10.1128/AEM.01039-09. Epub 2009 Jul 31.

11.

A dimer of the Toll-like receptor 4 cytoplasmic domain provides a specific scaffold for the recruitment of signalling adaptor proteins.

Núñez Miguel R, Wong J, Westoll JF, Brooks HJ, O'Neill LA, Gay NJ, Bryant CE, Monie TP.

PLoS One. 2007 Aug 29;2(8):e788.

12.

Potential prophylactic value of bovine colostrum in necrotizing enterocolitis in neonates: an in vitro study on bacterial attachment, antibody levels and cytokine production.

Brooks HJ, McConnell MA, Corbett J, Buchan GS, Fitzpatrick CE, Broadbent RS.

FEMS Immunol Med Microbiol. 2006 Dec;48(3):347-54. Epub 2006 Sep 21.

13.

Comparison of Campylobacter jejuni PFGE and Penner subtypes in human infections and in water samples from the Taieri River catchment of New Zealand.

Eyles RF, Brooks HJ, Townsend CR, Burtenshaw GA, Heng NC, Jack RW, Weinstein P.

J Appl Microbiol. 2006 Jul;101(1):18-25.

14.
15.

Oxidative and nitrosative responses of the chicken macrophage cell line MQ-NCSU to experimental Salmonella infection.

Withanage GS, Mastroeni P, Brooks HJ, Maskell DJ, McConnell I.

Br Poult Sci. 2005 Jun;46(3):261-7.

PMID:
16050178
16.

Diagnosis of helicobacter pylori infection by polymerase chain reaction: is it worth it?

Brooks HJ, Ahmed D, McConnell MA, Barbezat GO.

Diagn Microbiol Infect Dis. 2004 Sep;50(1):1-5.

PMID:
15380272
17.

Occurrence and virulence factors of non-O157 Shiga toxin-producing Escherichia coli in retail meat in Dunedin, New Zealand.

Brooks HJ, Mollison BD, Bettelheim KA, Matejka K, Paterson KA, Ward VK.

Lett Appl Microbiol. 2001 Feb;32(2):118-22.

18.

Non-O157 Vero cytotoxin producing Escherichia coli: aetiological agents of diarrhoea in children in Dunedin, New Zealand.

Brooks HJ, Bettelheim KA, Todd B, Holdaway MD.

Comp Immunol Microbiol Infect Dis. 1997 Feb;20(2):163-70.

PMID:
9208202
19.
20.

In vivo attachment of E coli to human epithelial cells.

Reid G, Brooks HJ.

N Z Med J. 1984 Jul 11;97(759):439-42.

PMID:
6146955
21.
24.

Uropathogenic properties of Escherichia coli in recurrent urinary-tract infection.

Brooks HJ, O'Grady F, McSherry MA, Cattell WR.

J Med Microbiol. 1980 Feb;13(1):57-68.

PMID:
6102156
25.

Campylobacter enteritis and Yersinia enterocolitica infection in New Zealand.

Watson LA, Brooks HJ, Scrimgeour G.

N Z Med J. 1979 Sep 26;90(644):240-2.

PMID:
292870
26.

The increasing isolation of Serratia species from clinical specimens.

Brooks HJ, Chambers TJ, Tabaqchali S.

J Hyg (Lond). 1979 Feb;82(1):31-40.

27.

Serratia marcescens in hospital practice.

Tabaqchali S, Chambers TJ, Brooks HJ.

Lancet. 1977 Feb 5;1(8006):306-7. No abstract available.

PMID:
64829
28.

Periurethral enterobacterial carriage in pathogenesis of recurrent urinary infection.

Cattell WR, McSherry MA, Northeast A, Powell E, Brooks HJ, O'Grady F.

Br Med J. 1974 Oct 19;4(5937):136-9.

Supplemental Content

Loading ...
Support Center